Evidence map›Paper›PMID 37399330›Full record

ArticleJournal of psychoactive drugs

Correlates of Perceived Discrimination Related to Substance Use Disorders Among Patients in Methadone Maintenance Treatment.

Uzoji Nwanaji-Enwerem, Mark Beitel, David E Oberleitner, Marina Gaeta Gazzola, Kathryn F Eggert, Lindsay M S Oberleitner, Oluwole Jegede, Xiaoying Zheng, Nancy S Redeker, Lynn M Madden and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of psychoactive drugs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Uzoji Nwanaji-EnweremYale School of Nursing, New Haven, CT, USA.
Mark BeitelDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
David E OberleitnerDepartment of Research, APT Foundation, New Haven, CT, USA.
Marina Gaeta GazzolaDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Kathryn F EggertDepartment of Research, APT Foundation, New Haven, CT, USA.
Lindsay M S OberleitnerDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Oluwole JegedeDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Xiaoying ZhengDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Nancy S RedekerYale School of Nursing, New Haven, CT, USA.
Lynn M MaddenDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Declan T BarryDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Yale University · USAPT Foundation · USUniversity of Bridgeport · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research CentersRM1DA055310 · NIDA · YALE UNIVERSITY · PI BARRY, DECLAN T., BECKER, WILLIAM C · 2021 to 2025
$12.9M
The Collaboration Linking Opioid Use Disorder and Sleep ("CLOUDS") StudyU01HL150596 · NHLBI · YALE UNIVERSITY · PI BARRY, DECLAN T., REDEKER, NANCY S · 2019 to 2024
$5.1M
Chronic Pain and Opioid Dependence Assessment and TreatmentK23DA024050 · NIDA · YALE UNIVERSITY · PI BARRY, DECLAN T. · 2008 to 2012
$901k
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS U01 HL150596NIDA NIH HHS K23 DA024050NIDA NIH HHS RM1 DA055310
6 · The paper itself

Abstract

This study sought to examine demographic, treatment-related, and diagnosis-related correlates of substance use disorder (SUD)-related perceived discrimination among patients receiving methadone maintenance treatment (MMT). Participants were 164 patients at nonprofit, low-barrier-to-treatment-access MMT programs. Participants completed measures of demographics, diagnosis-related characteristics (Brief Symptom Inventory (BSI-18) and Depressive Experiences Questionnaire (DEQ)), and treatment-related characteristics. Perceived discrimination was measured on a seven-point Likert-type scale ranging from 1 ("Not at all") to 7 ("Extremely") in response to the item: "I often feel discriminated against because of my substance abuse." Given the variable's distribution, a median split was used to categorize participants into "high" and "low" discrimination groups. Correlates of high and low discrimination were analyzed with bivariate and logistic regression models. Ninety-four participants (57%) reported high SUD-related perceived discrimination. Bivariate analyses identified six statistically significant correlates of SUD-related perceived discrimination (

Indexed as

MethadoneOpiate Substitution TreatmentOpioid-Related DisordersAdultDepressionFemaleHumansMaleMiddle AgedPerceptionSubstance-Related DisordersSurveys and QuestionnairesMethadoneDepressiondiscriminationmethadoneopioid use disorderrace

Identifiers

PMID37399330
PMCPMC10761588
OpenAlexW4382931483

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.